Integration of tumor inflammation, cell proliferation, and traditional biomarkers improves prediction of immunotherapy resistance and response

BACKGROUND: Contemporary to the rapidly evolving landscape of cancer immunotherapy is the equally changing understanding of immune tumor microenvironments (TMEs) which is crucial to the success of these therapies. Their reliance on a robust host immune response necessitates clinical grade measuremen...

Descripción completa

Detalles Bibliográficos
Autores principales: Pabla, Sarabjot, Seager, R. J., Van Roey, Erik, Gao, Shuang, Hoefer, Carrie, Nesline, Mary K., DePietro, Paul, Burgher, Blake, Andreas, Jonathan, Giamo, Vincent, Wang, Yirong, Lenzo, Felicia L., Schoenborn, Margot, Zhang, Shengle, Klein, Roger, Glenn, Sean T., Conroy, Jeffrey M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265007/
https://www.ncbi.nlm.nih.gov/pubmed/34233760
http://dx.doi.org/10.1186/s40364-021-00308-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8265007/
https://www.ncbi.nlm.nih.gov/pubmed/34233760
http://dx.doi.org/10.1186/s40364-021-00308-6

Ejemplares similares